Abstract:An inclusion complex of sulfonamide derived from L-valine (dimethyl 2, 2′- (sulfonylbis (azanediyl)) bis (3-methylbutanoate), (DSBM), with cyclodextrin has been synthesized and characterized using different spectroscopic techniques: FT-IR, 1 H NMR, 13 C NMR, 2D NMR, and UV–Visible. The DFT/B3LYP method was utilized to perform theoretical calculations in order to examine vibrational properties, determine NBO (natural bond orbital) energies, and clarify the frontier molecular orbitals (FMOs). Time-dependent density functional theory TD-DFT calculations were realized for the optimized DSBM and its complex structures. To elucidate the different intermolecular interactions in the complex, a detailed analysis of the topological charge density based on the quantum theory of atoms in molecules (QTAIM) was performed. Moreover, the DHPS from Staphylococcus aureus (PDB code: 1AD4), HIV-1 reverse transcriptase (PDB code: 4KV8), and HIV-1 protease (PDB code: 4Q5M) were selected for molecular docking study. The in silico results indicate that the DSBM and β-CD inclusion complex can be used as a better inhibitor of DHPS enzyme from Staphylococcus aureus bacteria strain. The interaction between DSBM-β-CD inclusion complex and HIV-1 reverse transcriptase (RT) exhibits a higher binding energy (− 147.80 kcal/mol) than that of the drug reference nevirapine (− 103.43 kcal/mol) and DSBM (− 85.53 kcal/mol). The in silico evaluation against HIV-1 protease reveal that the inclusion complex presents antiviral properties better than the free ligand DSBM. Therefore, the in vitro antioxidant activity was evaluated using DPPH radical scavenging. The data show that the cyclodextrin inclusion complex displays an antioxidant activity better than the DSBM and ascorbic acid with inhibition concentration values of 472.71, 427.59, and 513.01 μg/mL for DSBM-β-CD complex, DSBM, and ascorbic acid, respectively. These values reveal that the complexation with β-CD enhances the antioxidant properties. The antimicrobial activity was realized against Staphylococcus aureus (ATCC 6538), Escherichia coli (ATCC 4157), and Bacillus subtilis (ATCC 9372) bacteria strains; Candida albicans (ATCC 24433) yeast strain; and Aspergillus niger (ATCC 16888) mold strain. The results show that the synthesized compounds are more active against Aspergillus niger with an inhibition zone diameter of 90 mm for both DSBM and its β-CD complex. These results indicate that the formed compounds can act as potent antifungal agents.

Water-soluble inclusion complexes for a novel anti-viral agent with low toxicity; Oseltamivir with the β-cyclodextrins

A novel and water-soluble material for coronavirus inactivation from oseltamivir in the cavity of methyl and sulfated-β-cyclodextrins through inclusion complexation

Chemico-pharmaceutical investigations of an inclusion complex formed with valacyclovir and γ-cyclodextrin optimized by molecular docking for innovative applications as topical gel

Innovated formulation of oseltamivir powder for suspension with stability study after reconstitution using a developed ion-pair reversed phase high-performance liquid chromatography method

Synthesis, structural characterization, computational studies, and in silico and in vitro biological activities of cyclodextrin inclusion complex with sulfonamide derived from L-valine as antimicrobial and anti-HIV-1 agents

Lyotropic liquid crystal emulsions of LAVR-289: Influence of internal mesophase structure on cytotoxicity and in-vitro antiviral activity

Development and characterization of a cyclodextrin-based delivery system for enhanced pharmacokinetic and safety profile of oseltamivir

Design, synthesis and biological evaluation of water-soluble per-O-methylated cyclodextrin-C60 conjugates as anti-influenza virus agents.

Synthesis and structure-activity relationship studies of water-soluble β-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents.

Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity

A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents

Synthesis and bioevaluation of water-soluble β-cyclodextrin–diterpene acid conjugates

Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability

Structure-Based Optimization of N-Substituted Oseltamivir Derivatives As Potent Anti-Influenza A Virus Agents with Significantly Improved Potency Against Oseltamivir-Resistant N1-H274Y Variant

Encapsulation of Vortioxetine with Cyclodextrins Via Host–guest Inclusion Complex: Synthesis, Characterization, Solubility, and in Vitro Dissolution Studies

Supramolecular amphiphiles of Beta-cyclodextrin and Oleylamine for enhancement of vancomycin delivery

Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant

Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties

Improved Degradation of Oseltamivir Phosphate, an Antiviral Drug, through Hydrodynamic Cavitation based Hybrid Advanced Oxidation Processes: An insight into geometrical parameter optimization

A Novel N-heterocycles Substituted Oseltamivir Derivatives As Potent Inhibitors of Influenza Virus Neuraminidase: Discovery, Synthesis and Biological Evaluation

Rapid Enantioselective and Diastereoconvergent Hybrid Organic/Biocatalytic Entry into the Oseltamivir Core